Immunodiagnostic Systems Holdings Plc (IDH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -1,933 | -959 | -754 | -197 | 724 |
| Other Working Capital | -1,314 | 232 | -2,364 | 1,043 | 474 |
| Other Operating Activity | 8,790 | 6,507 | 5,634 | 7,590 | 6,990 |
| Operating Cash Flow | $5,543 | $5,780 | $2,516 | $8,436 | $8,188 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,638 | -2,096 | -1,359 | -759 | -1,607 |
| Purchase Sale Intangibles | -2,198 | -2,492 | -2,639 | -3,039 | -3,388 |
| Other Investing Activity | 173 | 162 | 128 | 169 | 169 |
| Investing Cash Flow | $-4,663 | $-4,426 | $-3,870 | $-3,629 | $-4,826 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -79 | -86 | -96 | -410 |
| Common Stock Issued | N/A | 0 | 83 | 0 | 410 |
| Common Stock Repurchased | 0 | -1,358 | -147 | N/A | N/A |
| Dividend Paid | -201 | -500 | -1,177 | -353 | -876 |
| Other Financing Activity | -737 | -82 | -79 | -88 | -109 |
| Financing Cash Flow | $-938 | $-2,019 | $-1,406 | $-537 | $-985 |
| Exchange Rate Effect | -71 | -155 | -202 | 671 | 447 |
| Beginning Cash Position | 27,713 | 28,533 | 31,495 | 26,554 | 23,730 |
| End Cash Position | 27,584 | 27,713 | 28,533 | 31,495 | 26,554 |
| Net Cash Flow | $-58 | $-665 | $-2,760 | $4,270 | $2,377 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,543 | 5,780 | 2,516 | 8,436 | 8,188 |
| Capital Expenditure | -4,836 | -4,588 | -3,998 | -4,510 | -5,183 |
| Free Cash Flow | 707 | 1,192 | -1,482 | 3,926 | 3,005 |